Cargando…
Low-Dose Naltrexone in Rheumatological Diseases
BACKGROUND: Naltrexone has been approved for alcohol and opioid abuse by the FDA. At low-dose naltrexone (LDN) has been used in several diseases including chronic pain and autoimmune conditions, including rheumatic disorders. AIM: To review the use of LDN in rheumatic diseases: systemic sclerosis (S...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Mediterranean Journal of Rheumatology (MJR)
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201089/ https://www.ncbi.nlm.nih.gov/pubmed/37223594 http://dx.doi.org/10.31138/mjr.34.1.1 |